MMP9 and Alzheimer disease: Based on a study with 31 patients with AD and 15 normal controls, Gu et al. [21] concluded that MMP9 is a good inflammatory biomarker for AD, since its levels in plasma neuronally derived extracellular vesicles were higher in AD patients than in normal controls.